These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 16015535)
1. Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Kong FM; Ten Haken R; Eisbruch A; Lawrence TS Semin Oncol; 2005 Apr; 32(2 Suppl 3):S42-54. PubMed ID: 16015535 [TBL] [Abstract][Full Text] [Related]
2. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Kong FM; Hayman JA; Griffith KA; Kalemkerian GP; Arenberg D; Lyons S; Turrisi A; Lichter A; Fraass B; Eisbruch A; Lawrence TS; Ten Haken RK Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1075-86. PubMed ID: 16647222 [TBL] [Abstract][Full Text] [Related]
3. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention. Mehta V Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):5-24. PubMed ID: 15963660 [TBL] [Abstract][Full Text] [Related]
4. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Yorke ED; Jackson A; Rosenzweig KE; Merrick SA; Gabrys D; Venkatraman ES; Burman CM; Leibel SA; Ling CC Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):329-39. PubMed ID: 12243805 [TBL] [Abstract][Full Text] [Related]
5. Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma. Menoux I; Antoni D; Mazzara C; Labani A; Charloux A; Quoix E; Falcoz PE; Truntzer P; Noël G Cancer Radiother; 2020 Apr; 24(2):120-127. PubMed ID: 32173269 [TBL] [Abstract][Full Text] [Related]
6. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Willner J; Jost A; Baier K; Flentje M Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954 [TBL] [Abstract][Full Text] [Related]
7. Radiotherapy or chemotherapy followed by radiotherapy with or without amifostine in locally advanced lung cancer. Antonadou D Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):50-8. PubMed ID: 11917285 [TBL] [Abstract][Full Text] [Related]
8. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Wang S; Liao Z; Wei X; Liu HH; Tucker SL; Hu CS; Mohan R; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1399-407. PubMed ID: 16997503 [TBL] [Abstract][Full Text] [Related]
9. Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study. Wang S; Campbell J; Stenmark MH; Zhao J; Stanton P; Matuszak MM; Ten Haken RK; Kong FS Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):615-621. PubMed ID: 28581403 [TBL] [Abstract][Full Text] [Related]
10. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949 [TBL] [Abstract][Full Text] [Related]
11. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer. Parashar B; Edwards A; Mehta R; Pasmantier M; Wernicke AG; Sabbas A; Kerestez RS; Nori D; Chao KS Am J Clin Oncol; 2011 Apr; 34(2):160-4. PubMed ID: 20498591 [TBL] [Abstract][Full Text] [Related]
13. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy. Piotrowski T; Matecka-Nowak M; Milecki P Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028 [TBL] [Abstract][Full Text] [Related]
14. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955 [TBL] [Abstract][Full Text] [Related]
15. Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer. Mazeron R; Etienne-Mastroianni B; Pérol D; Arpin D; Vincent M; Falchero L; Martel-Lafay I; Carrie C; Claude L Int J Radiat Oncol Biol Phys; 2010 May; 77(1):38-43. PubMed ID: 20171801 [TBL] [Abstract][Full Text] [Related]
16. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548 [TBL] [Abstract][Full Text] [Related]
17. Radiation and third-generation chemotherapy. Chen Y; Okunieff P Hematol Oncol Clin North Am; 2004 Feb; 18(1):55-80. PubMed ID: 15005281 [TBL] [Abstract][Full Text] [Related]
18. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451 [TBL] [Abstract][Full Text] [Related]
19. Lung Size and the Risk of Radiation Pneumonitis. Briere TM; Krafft S; Liao Z; Martel MK Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):377-84. PubMed ID: 26675062 [TBL] [Abstract][Full Text] [Related]
20. Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis. Mac Manus MP; Ding Z; Hogg A; Herschtal A; Binns D; Ball DL; Hicks RJ Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1365-71. PubMed ID: 20675076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]